Genedrive (D6M) Ratios
Genedrive Ratios
DE:D6M's free cash flow for Q2 2025 was $-1.84M. For the 2025 fiscal year, DE:D6M's free cash flow was decreased by $-1.00K and operating cash flow was $-1.84M. See a summary of the company’s cash flow.
| Ratios | Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.95 | 4.60 | 1.68 | 6.35 | 3.52 |
| Quick Ratio | 1.64 | 4.33 | 1.47 | 5.61 | 3.09 |
| Cash Ratio | 0.86 | 3.60 | 1.06 | 4.54 | 2.00 |
| Solvency Ratio | -3.75 | -4.74 | -1.99 | -4.38 | -0.35 |
| Operating Cash Flow Ratio | -3.70 | -2.61 | -1.54 | -4.56 | -4.03 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 1.31M | $ 5.18M | $ 1.65M | $ 5.41M | $ 3.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.05 | 0.00 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.12 | 0.00 | 0.03 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.11 | 0.00 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.96 | 1.27 | 2.21 | 1.18 | 1.36 |
| Debt Service Coverage Ratio | 0.00 | -568.00 | -156.94 | -275.56 | -0.89 |
| Interest Coverage Ratio | 0.00 | -442.67 | -168.52 | -350.94 | -23.33 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Debt to EBITDA | 0.22 | 0.69 | 0.41 | 0.85 | 1.79 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 50.70% | -361.82% | -7800.00% | -556.33% |
| EBIT Margin | -710.21% | -1544.51% | -10818.18% | -11459.18% | -235.37% |
| EBITDA Margin | -701.44% | -1495.21% | -10356.36% | -10948.98% | -199.56% |
| Operating Profit Margin | -704.19% | -1060.28% | -9498.18% | -11459.18% | -797.96% |
| Pretax Profit Margin | -710.21% | -1546.91% | -10874.55% | -11491.84% | -269.58% |
| Net Profit Margin | -684.69% | -1412.18% | -9363.64% | -9540.82% | -100.58% |
| Continuous Operations Profit Margin | -684.69% | -1412.18% | -9363.64% | -9540.82% | -100.58% |
| Net Income Per EBT | 96.41% | 91.29% | 86.11% | 83.02% | 37.31% |
| EBT Per EBIT | 100.86% | 145.90% | 114.49% | 100.28% | 33.78% |
| Return on Assets (ROA) | -185.83% | -104.04% | -114.27% | -70.61% | -14.17% |
| Return on Equity (ROE) | -363.77% | -132.02% | -252.33% | -83.32% | -19.24% |
| Return on Capital Employed (ROCE) | -374.13% | -99.12% | -253.59% | -100.07% | -152.62% |
| Return on Invested Capital (ROIC) | -360.69% | -90.17% | -197.12% | -82.85% | -55.12% |
| Return on Tangible Assets | -185.83% | -104.04% | -114.27% | -70.61% | -14.17% |
| Earnings Yield | -67.35% | -219.85% | -39.07% | -39.35% | -2.60% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.71 | 4.01 | 0.06 | 0.05 | 0.00 |
| Payables Turnover | 0.11 | 0.37 | 0.59 | 22.38 | 10.27 |
| Inventory Turnover | 0.16 | 0.65 | 0.48 | 5.18 | 8.11 |
| Fixed Asset Turnover | 5.88 | 2.88 | 0.14 | 0.24 | 2.28 |
| Asset Turnover | 0.27 | 0.07 | 0.01 | 0.01 | 0.14 |
| Working Capital Turnover Ratio | 0.24 | 0.15 | 0.02 | 0.01 | 0.12 |
| Cash Conversion Cycle | -363.51 | -328.61 | 5980.28 | 7525.54 | 9.47 |
| Days of Sales Outstanding | 513.58 | 91.07 | 5846.64 | 7471.33 | 0.00 |
| Days of Inventory Outstanding | 2331.64 | 563.02 | 754.43 | 70.53 | 45.01 |
| Days of Payables Outstanding | 3208.73 | 982.69 | 620.79 | 16.31 | 35.54 |
| Operating Cycle | 2845.22 | 654.08 | 6601.07 | 7541.86 | 45.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | -0.04 | -0.05 | -0.09 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.04 | -0.06 | -0.09 |
| Dividend Paid and CapEx Coverage Ratio | -221.78 | -129.93 | -72.62 | -74.35 | -49.85 |
| Capital Expenditure Coverage Ratio | -221.78 | -129.93 | -72.62 | -74.35 | -49.85 |
| Operating Cash Flow Coverage Ratio | 0.00 | -198.32 | -15.67 | -288.13 | -43.56 |
| Operating Cash Flow to Sales Ratio | -6.68 | -7.52 | -68.65 | -94.08 | -7.55 |
| Free Cash Flow Yield | -65.97% | -117.99% | -29.04% | -39.33% | -19.92% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.48 | -0.45 | -2.56 | -2.54 | -38.41 |
| Price-to-Sales (P/S) Ratio | 10.17 | 6.42 | 239.69 | 242.46 | 38.64 |
| Price-to-Book (P/B) Ratio | 5.40 | 0.60 | 6.46 | 2.12 | 7.39 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.52 | -0.85 | -3.44 | -2.54 | -5.02 |
| Price-to-Operating Cash Flow Ratio | -1.52 | -0.85 | -3.49 | -2.58 | -5.12 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.01 | 3.53 | -0.01 | 0.39 |
| Enterprise Value Multiple | -1.23 | 0.26 | -1.90 | -1.36 | -17.57 |
| Enterprise Value | 6.59M | -1.95M | 10.82M | 7.31M | 24.09M |
| EV to EBITDA | -1.23 | 0.26 | -1.90 | -1.36 | -17.57 |
| EV to Sales | 8.62 | -3.89 | 196.78 | 149.13 | 35.07 |
| EV to Free Cash Flow | -1.29 | 0.51 | -2.83 | -1.56 | -4.56 |
| EV to Operating Cash Flow | -1.29 | 0.52 | -2.87 | -1.59 | -4.65 |
| Tangible Book Value Per Share | 0.00 | 0.03 | 0.02 | 0.07 | 0.06 |
| Shareholders’ Equity Per Share | 0.00 | 0.03 | 0.02 | 0.07 | 0.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.04 | 0.09 | 0.14 | 0.17 | 0.63 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Net Income Per Share | -0.01 | -0.04 | -0.05 | -0.06 | -0.01 |
| Tax Burden | 0.96 | 0.91 | 0.86 | 0.83 | 0.37 |
| Interest Burden | 1.00 | 1.00 | 1.01 | 1.00 | 1.15 |
| Research & Development to Revenue | 5.54 | 8.33 | 71.35 | 79.00 | 6.56 |
| SG&A to Revenue | 2.75 | 3.27 | 24.64 | 36.59 | 2.42 |
| Stock-Based Compensation to Revenue | 0.11 | 0.12 | 1.75 | 0.78 | 0.01 |
| Income Quality | 0.94 | 0.71 | 0.72 | 0.99 | 7.50 |
Currency in GBP